| Cartan Capital Invests in Proto Hologram |
Globe Newswire |
12/22 |
09:36 |
| Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus |
Globe Newswire |
12/21 |
07:00 |
| HotelPlanner Celebrates 20 Years Serving All Travelers |
Globe Newswire |
12/20 |
09:00 |
| TuneIn Offers Listeners the Ultimate Soundtrack for the Holiday Season with Eight New (And Free) Stations |
Globe Newswire |
12/14 |
09:30 |
| CARGO Therapeutics Reports Business Updates and Third Quarter 2023 Results |
Globe Newswire |
12/13 |
16:05 |
| RFK Sales and Marketing Team Honored with Prestigious MarCom Team Achievement Award |
Globe Newswire |
12/13 |
14:08 |
| TuneIn Partners with CountryLine Radio to Extend the Distribution of Garth Brooks? The BIG 615 Radio Station in the U.K. |
Globe Newswire |
12/13 |
07:00 |
| Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024 |
Globe Newswire |
12/12 |
16:02 |
| C4 Therapeutics Announces Positive Data from CFT7455 Phase 1 Trial in Relapsed/Refractory Multiple Myeloma |
Globe Newswire |
12/12 |
16:01 |
| SIRPant Immunotherapeutics Announces FDA Clearance of IND Application for SIRPant-MTM for the Treatment of Solid Tumors |
Globe Newswire |
12/12 |
08:00 |
| Sportradar Launches ?Future of Tennis Betting? with ATP |
Globe Newswire |
12/12 |
03:00 |
| Sandman Hotel Group and GreenStep Solutions are delighted to announce their new partnership |
Globe Newswire |
12/11 |
20:00 |
| Gracell Biotechnologies Presents Updated Clinical Data from FasTCAR-T GC012F Demonstrating Deep and Durable Responses in Newly Diagnosed Multiple Myeloma at ASH 2023 |
Globe Newswire |
12/11 |
19:30 |
| Nurix Therapeutics Presents Positive Clinical Data from Its Novel Bruton?s Tyrosine Kinase (BTK) Degrader Programs, NX-5948 and NX-2127, at the 65th American Society of Hematology (ASH) Annual Meeting |
Globe Newswire |
12/11 |
12:00 |
| Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting |
Globe Newswire |
12/11 |
08:30 |
| Latest Odronextamab Data in Relapsed/Refractory Follicular Lymphoma Showed Compelling Responses and Overall Maintenance of Patient-Reported Outcomes |
Globe Newswire |
12/10 |
19:30 |
| Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the Potential of ctDNA To Predict Long-term Outcomes |
Globe Newswire |
12/10 |
12:30 |
| Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023 |
Globe Newswire |
12/09 |
20:30 |
| Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101 |
Globe Newswire |
12/09 |
12:00 |
| Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the American Society of Hematology |
Globe Newswire |
12/09 |
12:00 |
| DraftKings Launches ?Pick6??A Peer-to-Peer Fantasy Sports Variant |
Globe Newswire |
12/06 |
11:48 |
| Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ? MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual Meeting |
Globe Newswire |
12/05 |
07:30 |
| Sportradar Appoints Jim Bombassei as Senior Vice President, Investor Relations and Corporate Finance |
Globe Newswire |
12/04 |
08:30 |
| Sana Biotechnology Publishes Early Clinical Data Showing that SC291, a CD19-directed Allogeneic CAR T Therapy, Evades Immune Detection in Presence of Intact Immune System |
Globe Newswire |
12/01 |
16:05 |
| Gift of Life Marrow Registry Drives Awareness, Celebrates Lives Saved at NHL Hockey Fights Cancer Night |
Globe Newswire |
12/01 |
10:22 |
